Santa Cruz Biotechnology delivers a wide array of JAM4 Antibodies for advanced research in cell adhesion and immune response. JAM4 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). JAM4, or Junctional Adhesion Molecule 4, plays a critical role in the regulation of tight junctions and the maintenance of epithelial barrier integrity. JAM4 is actively involved in leukocyte migration and has significant implications in inflammatory responses and tissue homeostasis. Understanding JAM4 function is essential for elucidating mechanisms underlying various diseases, including autoimmune disorders and cancer. Researchers worldwide rely on JAM4 monoclonal antibodies to explore cellular pathways and molecular interactions. Current investigations focus on how JAM4 influences cell-to-cell communication and barrier function in different tissue types. Ongoing studies examine JAM4's role in disease progression and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies for JAM4 continue to advance scientific understanding of cellular adhesion and immune system regulation.